StockData
Texas Instruments Inc logo

Texas Instruments Inc (TXN) operating KPIs

TXNNasdaqSemiconductors & Related DevicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 23, 2026Score 13/3058% above fair value
$300.84−12.10 (-3.87%)

Close on Oct 30, 2026Market cap $274.74BP/E 45.8Yield 1.83%

KPIs

Operating metrics that drive Texas Instruments's business · fiscal year ends December 31 (Calendar Fiscal Year: Q1 ends Mar 31, Q2 ends Jun 30, Q3 ends Sep 30, Q4/FY ends Dec 31; latest completed period Q3 FY2026 ended September 30, 2026)

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q3 26
2026-09-30
Q2 26
2026-06-30
Q1 26
2026-03-31
Q4 25
2025-12-31
Q3 25
2025-09-30
Q2 25
2025-06-30
Q1 25
2025-03-31
Q4 24
2024-12-31
Q3 24
2024-09-30
Q2 24
2024-06-30
Q1 24
2024-03-31
Q4 23
2023-12-31
Revenue($M)5
6,0555,4634,8254,4234,7424,4484,0694,0074,1513,8223,6614,077
Revenue YoY Growth (Published)(%)
28.0%23.0%19.0%10.0%14.0%16.0%11.0%-2.0%-8.0%-16.0%-16.0%-13.0%
Quarterly Revenue Guidance — Low (Target Quarter)($M)
5,6505,0004,3204,2204,4504,1703,7403,7003,9403,6503,4503,930
Quarterly Revenue Guidance — High (Target Quarter)($M)
6,1505,4004,6804,5804,8004,5304,0604,0004,2603,9503,7504,270
Next-Quarter Revenue Outlook — Low (Issued in Quarter)($M)
5,8005,6505,0004,3204,2204,4504,1703,7403,7003,9403,6503,450
Next-Quarter Revenue Outlook — High (Issued in Quarter)($M)
6,3006,1505,4004,6804,5804,8004,5304,0604,0004,2603,9503,750
Cost of Revenue($M)2
2,1682,1112,0261,9512,0191,8731,7561,6931,6771,6111,5661,646
Depreciation($M)
555547541537497460424416383363346322
Amortization of Capitalized Software($M)
212121202021201919181615
Gross Profit($M)
3,8873,3522,7992,4722,7232,5752,3132,3142,4742,2112,0952,431
Research and Development (R&D)($M)
530535510521518527517491492498478460
Selling, General and Administrative (SG&A)($M)
476490464446457485472446428465455438
Acquisition Charges($M)
71717000
Operating Profit (EBIT)($M)1
2,8742,3101,8081,4731,6631,5631,3241,3771,5541,2481,2861,533
Operating Profit YoY Growth (Published)(%)
73.0%48.0%37.0%7.0%7.0%25.0%3.0%-10.0%-18.0%-37.0%-34.0%-30.0%
Other Income (Expense), Net($M)
72694740624880112131130123113
Interest and Debt Expense($M)1
14114114114114113312813013113111698
Capitalized Interest Costs($M)
333332445563
Income Before Income Taxes (Pretax Income)($M)
2,8052,2381,7141,3721,5841,4781,2761,3591,5541,2471,2931,548
Provision for Income Taxes($M)1
38025816920922018397154192120188177
Effective Income Tax Rate(%)
14.0%12.0%10.0%0.4%14.0%12.0%8.0%0.0%12.0%10.0%15.0%0.2%
Net Income($M)6
2,4251,9801,5451,1631,3641,2951,1791,2051,3621,1271,1051,371
Net Income YoY Growth (Published)(%)
78.0%53.0%31.0%-3.0%0.0%15.0%7.0%-12.0%-20.0%-35.0%-35.0%-30.0%
Net Income Allocated to Common Stock — Basic($M)
2,4111,9691,5361,1561,3561,2881,1731,1991,3551,1211,1001,364
Net Income Allocated to Common Stock — Diluted($M)
2,4111,9691,5361,1561,3561,2881,1731,1991,3551,1211,1001,364
Undistributed Earnings Allocated to Participating RSUs — Basic($M)
14119787667657
Undistributed Earnings Allocated to Participating RSUs — Diluted($M)
14119787667657
Total Comprehensive Income($M)
2,4231,9811,5461,2271,3711,2861,1721,2601,3671,1301,1071,401
Diluted Earnings Per Share (EPS)($)6
2.622.141.681.271.481.411.281.311.471.221.201.49
Basic Earnings Per Share (EPS)($)
2.642.161.691.271.491.421.291.321.481.231.211.50
Diluted EPS YoY Growth (Published)(%)
77.0%52.0%31.0%-2.0%1.0%16.0%7.0%-13.0%-21.0%-35.0%-35.0%-30.0%
Quarterly Diluted EPS Guidance — Low (Target Quarter)($)
2.231.771.221.131.361.210.941.071.241.050.961.35
Quarterly Diluted EPS Guidance — High (Target Quarter)($)
2.572.051.481.391.601.471.161.291.481.251.161.57
Next-Quarter Diluted EPS Outlook — Low (Issued in Quarter)($)
2.452.231.771.221.131.361.210.941.071.241.050.96
Next-Quarter Diluted EPS Outlook — High (Issued in Quarter)($)
2.792.572.051.481.391.601.471.161.291.481.251.16
Dividends Declared Per Share($)1
1.421.421.421.421.361.361.361.361.301.301.301.30
Dividends Paid Per Share($)
1.421.421.421.421.361.361.361.361.301.301.301.30
Weighted-Average Diluted Shares(M)3
921920914-191491291609209199170
Weighted-Average Basic Shares(M)
914912909090990891009139129100
Dilutive Effect of Stock Options & RSUs(M)
785-154607770
Antidilutive Securities Excluded from Diluted EPS(M)
006041210-138141
Analog Segment — Revenue($M)6
4,9114,3653,9243,6153,7293,4523,2103,1743,2232,9282,8363,120
Analog Segment — Revenue YoY Growth(%)
32.0%26.0%22.0%14.0%16.0%18.0%13.0%2.0%-4.0%-11.0%-14.0%-12.0%
Analog Segment — Cost of Revenue($M)
1,6971,6361,5891,5301,5431,3951,2961,2691,2531,1931,154
Analog Segment — Gross Profit($M)
3,2142,7292,3352,0852,1862,0571,9141,9051,9701,7351,682
Analog Segment — Research & Development (R&D)($M)
377388369371371383369352350360349
Analog Segment — Selling, General & Administrative (SG&A)($M)
332349328319329349339316304328325
Analog Segment — Acquisition Charges($M)
000000
Analog Segment — Operating Profit($M)1
2,5051,9921,6381,3951,4861,3251,2061,2371,3161,0471,0081,280
Analog Segment — Operating Profit YoY Growth(%)
69.0%50.0%36.0%13.0%13.0%27.0%20.0%-3.0%-13.0%-28.0%-36.0%-29.0%
Embedded Processing Segment — Revenue($M)6
858788723662709679647613653615652752
Embedded Processing Segment — Revenue YoY Growth(%)
21.0%16.0%12.0%8.0%9.0%10.0%-1.0%-18.0%-27.0%-31.0%-22.0%-10.0%
Embedded Processing Segment — Cost of Revenue($M)
390380374358373365375334328318335
Embedded Processing Segment — Gross Profit($M)
468408349304336314272279325297317
Embedded Processing Segment — Research & Development (R&D)($M)
134129123134127125128120124117114
Embedded Processing Segment — Selling, General & Administrative (SG&A)($M)
107111104991011041041019210098
Embedded Processing Segment — Acquisition Charges($M)
000000
Embedded Processing Segment — Operating Profit($M)1
2271681227110885405810980105195
Embedded Processing Segment — Operating Profit YoY Growth(%)
110.0%98.0%205.0%22.0%-1.0%6.0%-62.0%-70.0%-58.0%-75.0%-56.0%-33.0%
Other Segment (DLP, Calculators, Custom ASICs) — Revenue($M)6
286310178146304317212220275279173205
Other Segment — Revenue YoY Growth(%)
-6.0%-2.0%-16.0%-34.0%11.0%14.0%23.0%7.0%-5.0%-22.0%-33.0%-25.0%
Other Segment — Cost of Revenue($M)
8195636310311385909610077
Other Segment — Gross Profit($M)
2052151158320120412713017917996
Other Segment — Research & Development (R&D)($M)
1918181620192019182115
Other Segment — Selling, General & Administrative (SG&A)($M)
3730322827322929323732
Other Segment — Acquisition Charges($M)
71717000
Other Segment — Operating Profit (Loss)($M)1
14215048769153788212912117358
Other Segment — Operating Profit YoY Growth(%)
106.0%-2.0%-38.0%-91.0%-47.0%-55.0%41.0%-1.0%-37.0%41.0%-32.0%
United States — Revenue (by Customer Headquarters)($M)1
2,3482,1311,7961,6791,8591,7071,5181,6221,6391,4081,2881,423
United States — Share of Revenue (by Customer HQ)(%)
39.0%39.0%37.0%39.0%38.0%37.0%39.0%37.0%35.0%
China — Revenue (by Customer Headquarters)($M)1
1,3921,2231,0249511,019985826821823745623732
China — Share of Revenue (by Customer HQ)(%)
23.0%22.0%21.0%21.0%22.0%20.0%20.0%19.0%17.0%
Europe, Middle East & Africa (EMEA) — Revenue (by Customer Headquarters)($M)2
1,2071,0751,070948972891936786880898955985
EMEA — Share of Revenue (by Customer HQ)(%)
20.0%20.0%22.0%20.0%20.0%23.0%21.0%23.0%26.0%
Germany — Share of Revenue (by Customer HQ)(%)
9.0%9.0%10.0%10.0%10.0%11.0%11.0%11.0%13.0%
Rest of Asia — Revenue (by Customer Headquarters)($M)1
635606555457505487438432431417401458
Rest of Asia — Share of Revenue (by Customer HQ)(%)
10.0%11.0%12.0%11.0%11.0%11.0%10.0%11.0%11.0%
Japan — Revenue (by Customer Headquarters)($M)1
369330289290313295275277313292330409
Japan — Share of Revenue (by Customer HQ)(%)
6.0%6.0%6.0%7.0%7.0%7.0%8.0%8.0%9.0%
Rest of World — Revenue (by Customer Headquarters)($M)1
1049891987483766965626470
Rest of World — Share of Revenue (by Customer HQ)(%)
2.0%2.0%2.0%2.0%2.0%2.0%2.0%2.0%2.0%
Operating Cash Flow (GAAP)($M)11
3,4192,7031,5202,2542,1901,8608491,9981,7321,5711,0171,924
Stock-Based Compensation (Cash Flow)($M)
951271098193129116788711610668
Gain/Loss on Sale of Assets($M)
085-200010-3129-1
Deferred Income Taxes (Cash Flow)($M)
-26-62-41153-50-87-21-33-85-71-140
Change in Accounts Receivable($M)
100275282-9912874141143-151-40116189
Change in Inventories($M)
67-90-109-2517125160-231-190-23-84-91
Change in Prepaid Expenses & Other Current Assets($M)
-16-29-8-1897-76232224-8
Change in Accounts Payable & Accrued Expenses($M)
75101-125208692-1218713102-77-10
Change in Accrued Compensation($M)
135142-447106121172-427115149168-444126
Change in Income Taxes Payable($M)
319-1413023107-7113211015512021258
Change in Pension & Postretirement Obligations($M)
-634713-18-931-24917-4
Change in Other Operating Assets & Liabilities, Net($M)
23-4967-48-13-3870291528572-11
Investing Cash Flow (GAAP)($M)6
-987-1,702-47-676-681-1,3351,253614-4870-3,329-311
Capital Expenditures (Additions to PP&E)($M)
4635146769251,1971,3051,1231,1921,3161,0641,2481,148
Proceeds from U.S. CHIPS Act Grant Incentives($M)
054955507502600000
Purchases of Short-Term Investments($M)
1,9692,4079358808051,1926479091,8452,0984,8642,565
Proceeds from Short-Term Investments($M)
1,4006361,0401,1101,2601,1302,8102,7302,7003,1302,6303,410
Proceeds from Asset Sales($M)
032501001021920
Other Investing Cash Flows($M)
-46-239-1915-3144-12-2630-40-9
Free Cash Flow (Non-GAAP: OCF − CapEx + CHIPS Act Grant Proceeds)($M)
2,9562,7381,3991,3291,068555-14806416507-231776
Financing Cash Flow (GAAP)($M)5
-1,881-890-1,149-1,664-1,242-244-2,539-2,001-1,396-1,3141,831-1,215
Repayments of Debt($M)
50000000750300-0300-0-0
Dividends Paid($M)
1,2981,2951,2911,2901,2361,2351,2381,2401,1871,1851,1831,181
Common Stock Repurchases($M)
482715840311930265353731871365
Proceeds from Common Stock Sales (Employee Plans)($M)
1644530942125115118871172486545
Other Financing Cash Flows($M)
-51-13-9-13-12-21-16-11-8-6-28-14
Total Cash Returned to Shareholders (Dividends + Repurchases)($M)
1,3461,3221,4491,6931,3551,5371,8911,7771,5051,2561,1861,246
Net Change in Cash and Cash Equivalents($M)
551111324-86267281-437611-151257-481398
Trailing 12-Month (TTM) Operating Cash Flow($M)3
9,8968,6677,8247,1536,8976,4396,1506,3186,2446,4496,2776,420
TTM Operating Cash Flow % of Revenue(%)
47.7%44.6%42.4%40.5%39.9%38.6%38.3%40.4%39.7%40.1%37.4%36.6%
TTM Operating Cash Flow YoY Growth(%)
43.0%35.0%27.0%13.0%10.0%0.0%-2.0%-2.0%-4.0%-12.0%-19.0%-26.0%
TTM Capital Expenditures($M)
2,5783,3124,1034,5504,8174,9364,6954,8204,7764,9555,3375,071
Trailing 12-Month (TTM) Free Cash Flow (Non-GAAP)($M)2
8,4226,5344,3512,9382,4151,7631,7151,4981,4681,4949401,349
TTM Free Cash Flow % of Revenue(%)
40.6%33.6%23.6%16.6%14.0%10.6%10.7%9.6%9.3%9.3%5.6%7.7%
TTM Free Cash Flow YoY Growth(%)
249.0%271.0%154.0%96.0%65.0%18.0%82.0%11.0%-11.0%-53.0%-79.0%-77.0%
Trailing 12-Month (TTM) Total Cash Returned to Shareholders($M)5
5,8105,8196,0346,4766,5606,7106,4295,7245,1934,8604,8084,850
TTM Total Cash Returned YoY Growth(%)
-11.0%-13.0%-6.0%13.0%26.0%38.0%34.0%18.0%-7.0%-25.0%-36.0%-39.0%
TTM Dividends Paid($M)
5,1745,1125,0524,9994,9494,9004,8504,7954,7364,6754,6154,557
TTM Dividends Paid YoY Growth(%)
5.0%4.0%4.0%4.0%4.0%5.0%5.0%5.0%5.0%6.0%6.0%6.0%
TTM Common Stock Repurchases($M)
6367079821,4771,6111,8101,579929457185193293
TTM Common Stock Repurchases YoY Growth(%)
-61.0%-61.0%-38.0%59.0%253.0%878.0%718.0%217.0%-58.0%-91.0%-94.0%-92.0%
Total Assets($M)6
36,83935,88234,39334,58535,00434,93333,75735,50935,32135,04834,88532,348
Total Current Assets($M)
16,88015,75713,79613,75013,87614,48413,08615,02615,87216,78917,44815,122
Cash and Cash Equivalents($M)
4,2113,6603,5493,2253,3113,0442,7633,2002,5892,7402,4832,964
Short-Term Investments($M)
3,9313,3411,5541,6561,8752,3152,2424,3806,1636,9487,9105,611
Accounts Receivable, Net($M)
2,6202,5202,2451,9632,0621,9341,8601,7191,8621,7111,6711,787
Allowance for Doubtful Accounts($M)
272232222124162123282016
Prepaid Expenses and Other Current Assets($M)
1,4461,6311,7532,1021,7992,3791,5341,2009621,2841,301761
Total Inventories, Net($M)4
4,6724,6054,6954,8044,8294,8124,6874,5274,2964,1064,0833,999
Raw Materials Inventory($M)
497467463465431402393395393405417420
Work in Process (WIP) Inventory($M)
2,4822,4072,3552,3722,4602,4292,3702,2142,0812,0722,1292,109
Finished Goods Inventory($M)
1,6931,7311,8771,9671,9381,9811,9241,9181,8221,6291,5371,470
Days of Inventory (DOI)(days)
194196209222215231240241231229235219
Property, Plant and Equipment, Net($M)2
11,83311,91112,14512,32012,34812,32111,81111,34711,80211,17410,4429,999
Property, Plant and Equipment, Gross($M)
18,07217,85617,87017,68217,31416,87816,03615,25415,46414,62213,73913,268
Accumulated Depreciation($M)
6,2395,9455,7255,3624,9664,5574,225-3,907-3,662-3,448-3,297-3,269
Goodwill($M)5
4,3304,3304,3304,3304,3624,3624,3624,3624,3624,3624,3624,362
Capitalized Software Licenses, Net($M)
301314323238237248263257229230231223
Long-Term Investments($M)
151515161717202326272834
Deferred Income Tax Assets, Net($M)
1,0541,0179739671,0891,0961,030936941905821757
Overfunded Retirement Plan Assets($M)
320316321324251253240233184167169173
Other Long-Term Assets($M)
2,1212,2372,5052,6562,8412,1692,9653,3481,9311,4211,4121,712
Cash & Equivalents Breakdown — Cash on Hand($M)5
395388404384354377379743716715706801
Cash & Equivalents — Money Market Funds($M)
1,3818231,1228447376825577625151,1051,4731,068
Cash & Equivalents — Corporate Debt Securities($M)
597541797517738502633694461372130349
Cash & Equivalents — U.S. Treasury & Agency Securities($M)
1,5391,6591,1361,2961,4321,3341,095752747548174696
Cash & Equivalents — Foreign Government Debt($M)
2992499018450149992491500050
Cash & Equivalents — Mutual Funds($M)
000000000000
Short-Term Investments Breakdown — U.S. Treasury & Agency Securities($M)5
2,4762,0329781,0351,1981,5931,6493,4854,6674,9625,2923,808
Short-Term Investments — Corporate Debt Securities($M)
9601,0135265225036234947961,1991,7402,3221,605
Short-Term Investments — Money Market Funds($M)
000000000000
Short-Term Investments — Foreign Government Debt($M)
4952965099174999999297246296198
Short-Term Investments — Cash on Hand($M)
000000000000
Short-Term Investments — Mutual Funds($M)
000000000000
Long-Term Investments Breakdown — Mutual Funds (Deferred Compensation)($M)6
111110111111101111111112
Long-Term Investments — Other Equity & Venture Investments($M)
445512
Long-Term Investments — Corporate Debt Securities($M)
000000000000
Long-Term Investments — U.S. Treasury & Agency Securities($M)
000000000000
Long-Term Investments — Money Market Funds($M)
000000000000
Long-Term Investments — Foreign Government Debt($M)
000000000000
Long-Term Investments — Cash on Hand($M)
000000000000
Total Liabilities($M)8
17,65417,87517,61518,31218,37718,53017,35118,60618,05317,83417,90215,451
Total Current Liabilities($M)
3,0173,2443,0963,1593,1182,4922,4893,6433,6863,6373,5533,320
Accounts Payable($M)
837680638756779881866820794858551802
Accrued Compensation($M)
675536389829724595418839721569399836
Income Taxes Payable($M)
6070138677953284159108178378172
Other Current Liabilities($M)
7958097821,0071,0369639211,0751,014983876911
Underfunded Retirement Plan Liabilities($M)
118123121124125122115110117113111108
Deferred Income Tax Liabilities, Net($M)
625563666063565354555563
Other Long-Term Liabilities($M)
1,5521,5501,4341,4151,5281,8101,8431,9541,3521,1871,3431,336
Total Stockholders' Equity($M)7
19,18518,00716,77816,27316,62716,40316,40616,90317,26817,21416,98316,897
Common Stock ($1 Par Value)($M)
1,7411,7411,7411,7411,7411,7411,7411,7411,7411,7411,7411,741
Additional Paid-In Capital($M)
5,2025,1294,7224,5114,4104,2454,0583,9353,8133,6663,4393,362
Retained Earnings($M)
54,28253,16152,48352,23652,36952,24952,19652,26252,30452,13552,19952,283
Treasury Common Stock (At Cost)($M)
41,95541,94142,08442,13041,74441,67641,442-40,895-40,395-40,128-40,193-40,284
Treasury Common Stock Shares(M)
827828831834832832832830829828831832
Accumulated Other Comprehensive Income (Loss)($M)
-85-83-84-85-149-156-147-140-195-200-203-205
Common Shares Issued(M)
1,7411,7411,7411,7411,7411,7411,7411,7411,7411,7411,7411,741
Total Carrying Value of Long-Term Debt (incl. Current Portion)($M)6
13,55514,05214,05014,04814,04614,04312,84813,59613,89313,89114,18911,223
Long-Term Debt (Non-Current)($M)
12,90512,90312,90113,54813,54614,04312,84812,84612,84412,84212,84010,624
Current Portion of Long-Term Debt($M)
6501,1491,149500500007501,0491,0491,349599
Commercial Paper / Short-Term Borrowings($M)
000000000000
Unamortized Debt Discount & Issuance Costs($M)
959810010210410710210410710911177
Estimated Fair Value of Total Long-Term Debt($M)
11,86013,09013,05013,24013,30013,15011,89012,48013,46012,78013,33010,680
Revolving Credit Facility Borrowing Capacity($M)
1,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,0001,000
1.125% Senior Notes due 2026 (Active Senior Notes Schedule)($M)19
0500500500500500500500500500500500
2.900% Senior Notes due 2027($M)
500500500500500500500500500500500500
4.600% Senior Notes due 2027($M)
6506506506506506506506506506506500
4.600% Senior Notes due 2028($M)
700700700700700700700700700700700700
2.250% Senior Notes due 2029($M)
750750750750750750750750750750750750
4.600% Senior Notes due 2029($M)
6506506506506506506506506506506500
1.750% Senior Notes due 2030($M)
750750750750750750750750750750750750
4.500% Senior Notes due 2030($M)
5505505505505505500
1.900% Senior Notes due 2031($M)
500500500500500500500500500500500500
3.650% Senior Notes due 2032($M)
400400400400400400400400400400400400
4.900% Senior Notes due 2033($M)
950950950950950950950950950950950950
4.850% Senior Notes due 2034($M)
6006006006006006006006006006006000
5.100% Senior Notes due 2035($M)
6506506506506506500
3.875% Senior Notes due 2039($M)
750750750750750750750750750750750750
4.150% Senior Notes due 2048($M)
1,5001,5001,5001,5001,5001,5001,5001,5001,5001,5001,5001,500
2.700% Senior Notes due 2051($M)
500500500500500500500500500500500500
4.100% Senior Notes due 2052($M)
300300300300300300300300300300300300
5.000% Senior Notes due 2053($M)
650650650650650650650650650650650650
5.150% Senior Notes due 2054($M)
7507507507507507507507507507507500
5.050% Senior Notes due 2063($M)
1,5501,5501,5501,5501,5501,5501,5501,5501,5501,5501,5501,200
1.375% Senior Notes due 2025 (Retired / Matured Senior Notes)($M)3
0000750750750750750
2.625% Senior Notes due 2024 (Retired)($M)
000300300
4.700% Senior Notes due 2024 (Retired)($M)
0300300300300
2.250% Senior Notes due 2023 (Retired)($M)
0
U.S. CHIPS Act Cumulative Receivable — Non-Current (Balance Sheet)($M)1
1,0361,1581,4931,6391,7341,0581,8692,246806464498859
U.S. CHIPS Act Cumulative Receivable — Current (Balance Sheet)($M)
1,1001,0051,4041,7091,5012,0251,195904621981999497
U.S. CHIPS Act Total Cash Benefit Realized (ITC + Direct Funding Grant)($M)1
79850555891182032605622031200
U.S. CHIPS Act Investment Tax Credit (ITC) Used to Reduce Income Taxes Payable($M)
793010894320305622031200
Income Tax Provision at Estimated Annual Effective Operating Tax Rate (Quarterly)($M)2
390309229249199166227170176
Discrete Income Tax Items (Quarterly)($M)
1051602916693550-12
U.S. Federal Statutory Income Tax Rate(%)
0.0%0.0%21.0%0.0%0.0%0.0%21.0%0.0%0.0%0.0%21.0%0.0%
U.S. Pension Plans — Net Periodic Benefit Cost (Credit)($M)3
6537986434310
U.S. Pension Plans — Service Cost($M)
212212212222
U.S. Pension Plans — Interest Cost($M)
656667667667
U.S. Pension Plans — Expected Return on Plan Assets($M)
546536457566
Foreign Pension Plans — Net Periodic Benefit Cost (Credit)($M)3
201212121125
Foreign Pension Plans — Service Cost($M)
344443444444
Foreign Pension Plans — Interest Cost($M)
161716151615141315131414
Foreign Pension Plans — Expected Return on Plan Assets($M)
172019182017181722191915
U.S. Postretirement Benefit Plans — Net Periodic Benefit Cost (Credit)($M)3
0100100-1-1-2-1-2
U.S. Postretirement Plans — Service Cost($M)
100001000101
U.S. Postretirement Plans — Interest Cost($M)
333433334334
U.S. Postretirement Plans — Expected Return on Plan Assets($M)
323423334636
Silicon Labs (SLAB) — Revenue($M)11
22821420820619317816616614510686.8
Silicon Labs (SLAB) — Cost of Revenue($M)
87.586.576.18784.779.97676.168.851.342.9
Silicon Labs (SLAB) — Gross Profit($M)
14112713211910897.890.290.376.655.143.9
Silicon Labs (SLAB) — Research & Development (R&D)($M)
9588.689.587.787.888.282.483.285.980.783.4
Silicon Labs (SLAB) — Selling, General & Administrative (SG&A)($M)
56.355.545.843.743.241.636.436.838.733.533.6
Silicon Labs (SLAB) — Total Operating Expenses($M)
151144135131131130119120125114117
Silicon Labs (SLAB) — Operating Income (Loss)($M)
-10.7-17.1-3.20-12.3-22.9-32.1-28.6-29.7-48-59.1-73.1
Silicon Labs (SLAB) — Net Income (Loss)($M)
-10.6-15.9-2.70-9.90-21.8-30.5-23.8-28.5-82.2-56.5-69.8
Silicon Labs (SLAB) — Diluted EPS($)
-0.32-0.48-0.07-0.30-0.67-0.94-0.72-0.88-2.56-1.77-2.16
Silicon Labs (SLAB) — Basic EPS($)
-0.32-0.48-0.07-0.30-0.67-0.94-0.72-0.88-2.56-1.77-2.20
Silicon Labs (SLAB) — Weighted-Average Diluted Shares(M)
33.233.00.0632.832.732.50.0832.332.131.9-1.11
Silicon Labs (SLAB) — Weighted-Average Basic Shares(M)
33.233.00.0632.832.732.50.0832.332.131.90.02
Silicon Labs (SLAB) — Operating Cash Flow($M)5
-14.54.908.3034.34.9048.110.131.616.1-71.818.5
Silicon Labs (SLAB) — Stock-Based Compensation($M)
25.621.120.72019.919.716.115.915.813.611
Silicon Labs (SLAB) — Depreciation($M)
6.10666.106.506.206.206.206.506.606.70
Silicon Labs (SLAB) — Capital Expenditures($M)
12.39.80106.408.704.8042.203.5023.80
Silicon Labs (SLAB) — Investing Cash Flow($M)
12.314.98.80-6.80-10.2-3.90-38.230.239.681.543.4
Silicon Labs (SLAB) — Financing Cash Flow($M)
-18.7-15.70-0.60-5.20-16.600.40-6.40-45.75.70
Silicon Labs (SLAB) — Total Assets($M)11
1,2531,2671,2691,2531,2211,2301,2231,2491,2501,3441,443
Silicon Labs (SLAB) — Cash and Cash Equivalents($M)
362383364341315325282303241192228
Silicon Labs (SLAB) — Short-Term Investments($M)
3555.879.497.610199.910166.698.3141212
Silicon Labs (SLAB) — Accounts Receivable, Net($M)
79.877.164.567.356.552.154.548.941.232.629.3
Silicon Labs (SLAB) — Total Inventories, Net($M)
12310395.682.280.983.4106140166198194
Silicon Labs (SLAB) — Work in Process (WIP) Inventory($M)
10085.477.567.864.95983.6117140173174
Silicon Labs (SLAB) — Finished Goods Inventory($M)
23.217.818.114.415.924.422.122.92624.820.5
Silicon Labs (SLAB) — Property, Plant & Equipment, Net($M)
131132129128131130132135139142146
Silicon Labs (SLAB) — Goodwill($M)
376376376376376376376376376376376
Silicon Labs (SLAB) — Intangible Assets, Net($M)
18.520.823.125.427.731.136.541.947.453.559.5
Silicon Labs (SLAB) — Total Liabilities($M)
158168175182160161143168157179234
Silicon Labs (SLAB) — Total Stockholders' Equity($M)
1,0951,0991,0941,0711,0611,0681,0801,0811,0931,1661,209

15 metrics have no data in the last 12 quarters — .

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Fiscal calendar & multi-source scope: Texas Instruments Incorporated (Nasdaq: TXN, CIK 0000097476) operates on a calendar fiscal year ending December 31 (latest completed period is Q3 FY2026 ended September 30, 2026). Data is synthesized from 95 SEC filings (Form 10-K FY2017–FY2025, Form 10-Q FY2018Q1–FY2026Q3, Form 8-K earnings releases & strategic updates FY2017Q4–FY2026Q3, Form SD Conflict Minerals Reports FY2019–FY2025, DEF 14A Proxy Statements FY2018–FY2025), SEC EDGAR XBRL for pending acquisition target Silicon Laboratories Inc. (Nasdaq: SLAB, CIK 0001038074), Taiwan MOPS monthly semiconductor foundry/OSAT revenue filings (TSMC, UMC, VIS, ASE, KYEC), and 7 FRED macro series.
  • Segment P&L Disaggregation (ASU 2023-07) & End-Market / Geographic Revenue (Groups 1–3): Covers complete Income Statement, Quarterly Revenue & Diluted EPS Guidance (both indexed to the target quarter and indexed to the release quarter), full Segment P&L disaggregation across Analog ($4,832M revenue / $2,443M operating profit in Q3 FY2026), Embedded Processing ($757M revenue / $126M operating profit in Q3 FY2026), and Other ($466M revenue / $252M operating profit in Q3 FY2026) including segment Cost of Revenue, Gross Profit, R&D, SG&A, Acquisition/Restructuring charges, and Goodwill, plus annual End-Market revenue shares (Industrial 33%, Automotive 33%, Personal Electronics 15%, Data Center/Enterprise 9%, Comms Equipment 3%, Other 7% in FY2025) and Geographic Revenue under both Customer Headquarters Location (active FY2020–FY2026Q3) and Product Shipment Destination (legacy FY2009–FY2023Q3).
  • Cash Flows, Free Cash Flow, Inventory by Stage, Investment Portfolio & Senior Notes Schedule (Groups 4–6): Covers GAAP Operating/Investing/Financing Cash Flows, Non-GAAP Free Cash Flow (OCF − CapEx + CHIPS Act Grant Proceeds), Total Cash Returned to Shareholders (Dividends + Repurchases), Trailing 12-Month (TTM) OCF, CapEx, FCF, FCF % of Revenue, and Cash Returned KPIs, Inventory by manufacturing stage (Raw Materials $414M, Work in Process $2,955M, Finished Goods $1,843M, Total $5,212M and 194 Days of Inventory at Q3 FY2026), Cash/Short-Term/Long-Term Investments by asset class, and 20 active Senior Notes tranches due 2026–2063 ($13.56B total carrying value at Q3 FY2026) plus 8 retired tranches.
  • U.S. CHIPS Act Incentives, Taxes, Pension/SBC, Facilities, Form SD, DEF 14A & External Benchmarks (Groups 7–12): Covers U.S. CHIPS and Science Act cumulative receivables ($1,546M non-current + $50M current at Q3 FY2026), ITC used to reduce taxes payable, and direct grant proceeds; Operating vs. Discrete quarterly income tax provisions; Unconditional Purchase Obligations ($2,761M at FY2025); U.S. & Foreign Pension and Postretirement benefit obligations, assets, and net periodic costs; Stock-Based Compensation by P&L line and Option/RSU activity; U.S. & International facility square footage; Form SD 3TG Conflict Minerals smelter conformance; DEF 14A CEO Pay Ratio & Pay vs. Performance; Silicon Labs (SLAB) financial history through Q2 FY2026; Taiwan MOPS monthly revenue; and FRED electronics/industrial/auto benchmarks.
  • No parent-only standalone financial statements exist under U.S. GAAP, so no Consolidated − Standalone subtraction is performed. All values are strictly as published (with verbatim quotes on hover for text-extracted metrics). The only arithmetic shown in table cells is period splitting (Q4 = full year − 9M; Q2 = 6M − Q1; Q3 = 9M − 6M), displayed in italic with the formula.

Data updated 2026-10-25.

Every KPI on its own page

Full history, chart, sources and a citation for each metric

Income Statement, Earnings & Business Outlook

Segment Performance & Full Segment P&L Disaggregation

End Markets, Geographic Revenue & Long-Lived Assets

Cash Flows, Free Cash Flow, Capital Allocation & TTM Owner Metrics

Balance Sheet, Inventory by Stage & Investment Portfolio

Debt Structure & Senior Notes Schedule

U.S. CHIPS Act Incentives, Tax Disaggregation & Purchase Commitments

Pension, Postretirement Benefit Plans & Stock-Based Compensation

Manufacturing Facilities, Workforce, Form SD Supply Chain & Governance

Pending Acquisition Target Benchmark: Silicon Laboratories Inc. (Nasdaq: SLAB)

Global Semiconductor Foundry & OSAT Monthly Revenue Trackers (Taiwan MOPS)

U.S. Electronics, Industrial CapEx & Automotive End-Market Macro Benchmarks (FRED)